A practical research guide to Sermorelin storage conditions, reconstitution procedures, refrigeration requirements, and shelf life — covering lyophilized powder handling, bacteriostatic water use, and how long reconstituted Sermorelin remains stable.
A direct research comparison of Tesamorelin and CJC-1295 — two GHRH receptor analogs with different half-lives, structural modifications, and pharmacokinetic profiles. Covers mechanism, DAC vs no-DAC distinctions, and research design considerations.
A mechanistic three-way comparison of Sermorelin, Tesamorelin, and Ipamorelin for GH-axis researchers — covering receptor targets, half-life differences, selectivity, and which compound fits which research design.
A research-focused review of oral peptide bioavailability — why most peptides are not orally bioavailable, which structural modifications improve GI survival, and what the published data says about oral CJC-1295, Ipamorelin, and Sermorelin formulations.
A mechanistic comparison of Ipamorelin and Sermorelin for researchers studying the growth hormone axis — covering receptor targets, selectivity, half-life differences, and which compound suits which research design.
A mechanistic comparison of Tesamorelin and MK-677 (Ibutamoren) for researchers studying the growth hormone axis — covering receptor targets, half-lives, selectivity profiles, and the key differences between a GHRH analog and a ghrelin mimetic.
Three GLP-receptor agonists now dominate the metabolic research compound market: semaglutide, tirzepatide, and retatrutide. They are related but not interchangeable.
A research-focused overview of peptide stacking — what it means to combine peptide compounds, which combinations appear most frequently in scientific literature, and the key considerations for multi-compound research protocols.